我有一头小毛驴
Lv6
1878 积分
2024-01-31 加入
-
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia
1天前
待确认
-
Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial
1天前
已完结
-
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
3天前
已完结
-
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
3天前
已完结
-
A fc-engineered NKG2D × B7-H3 bispecific antibody enhances the antitumor activity by orchestrating cytotoxic lymphocytes
3天前
已完结
-
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
4天前
已完结
-
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling
4天前
已完结
-
Inebilizumab for Treatment of IgG4-Related Disease
8天前
已完结
-
Inebilizumab for Treatment of IgG4-Related Disease
8天前
已完结
-
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
8天前
已完结